James Mullen
2021 - Editas Medicine
Compensation breakdown
| Non-Equity Incentive Plan | $361,644 |
|---|---|
| Option Awards | $5,780,000 |
| Salary | $540,865 |
| Other | $32,002 |
| Total | $6,714,511 |
Mullen received $5.8M in option awards, accounting for 86% of the total pay in 2021.
Mullen also received $361.6K in non-equity incentive plan, $540.9K in salary and $32K in other compensation.
Rankings
In 2021, James Mullen's compensation ranked 1,850th out of 12,415 executives tracked by ExecPay. In other words, Mullen earned more than 85.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,850 out of 12,415 | 85th |
Division Manufacturing | 688 out of 5,505 | 88th |
Major group Chemicals And Allied Products | 259 out of 2,375 | 89th |
Industry group Drugs | 220 out of 2,096 | 90th |
Industry Biological Products, Except Diagnostic Substances | 62 out of 449 | 86th |
Pay ratio
| James Mullen's Pay | $6,714,511 |
|---|---|
| Median Employee's Pay | $181,354 |
| Pay Ratio | 37to 1 |
In 2021, the annual total compensation of James Mullen was $6,714,511.
The annual total compensation of the median employee at Editas Medicine was $181,354.
The ratio of James Mullen's pay to the pay of median employee was therefore 37 to one.
Mullen's colleagues
We found five more compensation records of executives who worked with James Mullen at Editas Medicine in 2021.
2021
Mark Shearman
Editas Medicine
Chief Scientific Officer
2021
Michelle Robertson
Editas Medicine
Chief Financial Officer
2021
Bruce Eaton
Editas Medicine
Executive Vice President and Chief Business Officer
2021
Lisa Michaels
Editas Medicine
Chief Medical Officer
2021
Cynthia Collins
Editas Medicine